Abstract 9243: Multi-Omics Signatures of Circulating Very-Long-Chain Saturated Fatty Acids and Incident Coronary Heart Disease
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.9243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Zhiyuan Wu und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Circulating levels of very-long-chain saturated fatty acids (VLCSFAs) have been inversely associated with coronary heart disease (CHD) risk, but underlying biological mechanisms are less understood. We aimed to integrate data of apolipoproteins, lipidomics, metabolomics, gut microbiome, and human genetics for understanding the role of these factors in the associations of VLCSFAs with CHD risk.
Methods
We measured three plasma VLCSFAs (C20:0, C22:0, and C24:0) using gas-liquid chromatography in nested case-control studies of CHD and the Lifestyle Validation Study within the Nurses’ Health Studies and Health Professionals Follow-up Study. Associations between VLCSFAs and multi-omics features were assessed using multivariable linear regression. We then derived integrated multi-omics indices representing VLCSFA-related profiles using sparse canonical correlation analysis. The associations of these signatures and indices with incident CHD were evaluated in nested case-control and prospective cohort analyses.
Results
Higher VLCSFA levels were associated with distinct multi-omics patterns, including lower ApoC3 and higher HDL-associated ApoC1, reduced triacylglycerols and diacylglycerols alongside increased sphingomyelins, and elevated cholesteryl esters in plasma multi-omics measures, and lower abundance of E. bolteae in the gut microbiome. The derived multi-omics indices showed moderate correlations with VLCSFA levels (Spearman r = 0.39-0.68) and were consistently associated with lower risk of incident CHD. Per SD increase in the apolipoprotein, lipidomic, metabolomic, and gut microbial indices of these fatty acids was associated with hazard ratios of 0.67 (95% CI: 0.54-0.83), 0.80 (0.68-0.94), 0.81 (0.72-0.90), and 0.67 (0.53-0.85), respectively. These indices were also associated with lower plasma triglycerides and remnant cholesterol, and higher HDL cholesterol. Notably, the inverse associations of VLCSFAs with CHD were significantly stronger among individuals with higher genetic susceptibility to CHD, as assessed by a polygenic risk score.
Conclusions
Plasma VLCSFAs are linked to coordinated alterations across apolipoprotein, lipidomics, metabolomics, and gut microbiome, that consistently predict a favorable cardiometabolic profile associated with reduced CHD risk. These associations may be modified by genetic susceptibility, highlighting potential interactions between fatty acid metabolism and genetic risk in CHD development. Overall, these findings suggest that the VLCSFAs may lower CHD risk through modulation of, or shared variation with, multiple systems.
Zitieren
APA
Wu, Z., Liu, B., Wang, X., Eliassen, A. H., Clish, C., Rimm, E., Hu, Y., Zhang, C., Hu, F. B., & Sun, Q. (2026). Abstract 9243: Multi-Omics Signatures of Circulating Very-Long-Chain Saturated Fatty Acids and Incident Coronary Heart Disease. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.9243
Vancouver
Wu Z, Liu B, Wang X, Eliassen AH, Clish C, Rimm E, et al. Abstract 9243: Multi-Omics Signatures of Circulating Very-Long-Chain Saturated Fatty Acids and Incident Coronary Heart Disease. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.9243
BibTeX
@article{Wu2026,
author = {Wu, Zhiyuan and Liu, Binkai and Wang, Xiaowen and Eliassen, A Heather and Clish, Clary and Rimm, Eric and Hu, Yang and Zhang, Cuilin and Hu, Frank B and Sun, Qi},
title = {Abstract 9243: Multi-Omics Signatures of Circulating Very-Long-Chain Saturated Fatty Acids and Incident Coronary Heart Disease},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.9243}
}
EUVIMED